Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile.

Garcia-Broncano P, Maddali S, Einkauf KB, Jiang C, Gao C, Chevalier J, Chowdhury FZ, Maswabi K, Ajibola G, Moyo S, Mohammed T, Ncube T, Makhema J, Jean-Philippe P, Yu XG, Powis KM, Lockman S, Kuritzkes DR, Shapiro R, Lichterfeld M.

Sci Transl Med. 2019 Nov 27;11(520). pii: eaax7350. doi: 10.1126/scitranslmed.aax7350.

PMID:
31776292
2.

Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study.

Garcia-Broncano P, Medrano LM, Berenguer J, Brochado-Kith O, González-García J, Jiménez-Sousa MÁ, Quereda C, Sanz J, Téllez MJ, Díaz L, JIménez JL, Resino S; GESIDA 3603b Study Group.

J Infect. 2019 Oct 1. pii: S0163-4453(19)30292-0. doi: 10.1016/j.jinf.2019.09.020. [Epub ahead of print]

PMID:
31585189
3.

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study.

Aldámiz-Echevarría T, Resino S, Bellón JM, Jiménez-Sousa MA, Miralles P, Medrano LM, Carrero A, Díez C, Pérez-Latorre L, Fanciulli C, Garcia-Broncano P, Berenguer J.

J Transl Med. 2019 Jul 26;17(1):244. doi: 10.1186/s12967-019-1997-x.

4.

ART reduces T cell activation and immune exhaustion markers in HIV controllers.

Li JZ, Segal FP, Bosch RJ, Lalama CM, Roberts-Toler C, Delagreverie H, Getz R, Garcia-Broncano P, Kinslow J, Tressler R, Van Dam CN, Keefer M, Carrington M, Lichterfeld M, Kuritzkes D, Yu XG, Landay A, Sax PE; AIDS Clinical Trials Group Study A5308 Team.

Clin Infect Dis. 2019 May 25. pii: ciz442. doi: 10.1093/cid/ciz442. [Epub ahead of print]

PMID:
31131858
5.

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status.

Garcia-Broncano P, Medrano LM, Berenguer J, González-García J, Jiménez-Sousa MÁ, Carrero A, Hontañón V, Guardiola JM, Crespo M, Quereda C, Sanz J, García-Gómez AB, Jimenez JL, Resino S; GESIDA 3603b Study Group.

Cells. 2018 Nov 2;7(11). pii: E196. doi: 10.3390/cells7110196.

6.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.

Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S; GESIDA 3603b Study Group.

AIDS. 2018 Jun 1;32(9):1095-1105. doi: 10.1097/QAD.0000000000001787.

PMID:
29438197
7.

Pegylated Interferon-α-Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy-Treated HIV-1/Hepatitis C Virus-Coinfected Patients.

Hua S, Vigano S, Tse S, Zhengyu O, Harrington S, Negron J, Garcia-Broncano P, Marchetti G, Genebat M, Leal M, Resino S, Ruiz-Mateos E, Lichterfeld M, Yu XG.

Clin Infect Dis. 2018 Jun 1;66(12):1910-1917. doi: 10.1093/cid/cix1111.

8.

G2-S16 dendrimer as a candidate for a microbicide to prevent HIV-1 infection in women.

Ceña-Diez R, García-Broncano P, Javier de la Mata F, Gómez R, Resino S, Muñoz-Fernández M.

Nanoscale. 2017 Jul 13;9(27):9732-9742. doi: 10.1039/c7nr03034g.

PMID:
28675217
9.

Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection.

García-Broncano P, Ceña-Diez R, de la Mata FJ, Gómez R, Resino S, Muñoz-Fernández MÁ.

Eur J Pharmacol. 2017 Sep 15;811:155-163. doi: 10.1016/j.ejphar.2017.05.060. Epub 2017 May 31.

PMID:
28577966
10.

Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen.

Ceña-Diez R, García-Broncano P, de la Mata FJ, Gómez R, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2016 May 30;11:2443-50. doi: 10.2147/IJN.S104292. eCollection 2016.

11.

Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.

Ceña-Diez R, Vacas-Córdoba E, García-Broncano P, de la Mata FJ, Gómez R, Maly M, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2016 May 19;11:2147-62. doi: 10.2147/IJN.S95301. eCollection 2016.

12.

Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients.

García-Álvarez M, Berenguer J, Jiménez-Sousa MÁ, Vázquez-Morón S, Carrero A, Gutiérrez-Rivas M, Aldámiz-Echevarría T, López JC, García-Broncano P, Resino S.

AIDS. 2016 Apr 24;30(7):1069-74. doi: 10.1097/QAD.0000000000001007.

PMID:
27032111
13.

Dendronized Anionic Gold Nanoparticles: Synthesis, Characterization, and Antiviral Activity.

Peña-González CE, García-Broncano P, Ottaviani MF, Cangiotti M, Fattori A, Hierro-Oliva M, González-Martín ML, Pérez-Serrano J, Gómez R, Muñoz-Fernández MÁ, Sánchez-Nieves J, de la Mata FJ.

Chemistry. 2016 Feb 24;22(9):2987-99. doi: 10.1002/chem.201504262. Epub 2016 Jan 27.

PMID:
26875938
14.

IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.

Guzmán-Fulgencio M, Berenguer J, Jiménez-Sousa MA, Micheloud D, García-Álvarez M, Bellón JM, Aldámiz-Echevarría T, García-Broncano P, Catalán P, Diez C, Pineda-Tenor D, Resino S.

Eur J Clin Invest. 2015 Nov;45(11):1192-9. doi: 10.1111/eci.12539.

PMID:
26402121
15.

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.

Guzmán-Fulgencio M, Berenguer J, Jiménez-Sousa MA, Pineda-Tenor D, Aldámiz-Echevarria T, García-Broncano P, Carrero A, García-Álvarez M, Tejerina F, Diez C, Vazquez-Morón S, Resino S.

J Transl Med. 2015 Jun 30;13:206. doi: 10.1186/s12967-015-0577-y.

16.

FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.

Pineda-Tenor D, Berenguer J, Jiménez-Sousa MA, García-Alvarez M, Aldámiz-Echevarria T, Carrero A, Vázquez-Morón S, García-Broncano P, Diez C, Tejerina F, Guzmán-Fulgencio M, Resino S.

BMC Med. 2014 Nov 3;12:198. doi: 10.1186/s12916-014-0198-y.

17.

rs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.

Pineda-Tenor D, Berenguer J, Jiménez-Sousa MA, Carrero A, García-Álvarez M, Aldámiz-Echevarria T, García-Broncano P, Diez C, Guzmán-Fulgencio M, Fernández-Rodríguez A, Resino S.

AIDS Res Hum Retroviruses. 2015 Mar;31(3):326-34. doi: 10.1089/aid.2014.0195. Epub 2014 Oct 29.

18.

PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study.

García-Broncano P, Berenguer J, Fernández-Rodríguez A, Pineda-Tenor D, Jiménez-Sousa MÁ, García-Alvarez M, Miralles P, Aldámiz-Echevarria T, López JC, Micheloud D, Resino S.

J Transl Med. 2014 Aug 27;12:235. doi: 10.1186/s12967-014-0235-9.

19.

Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV-coinfected patients.

Pineda-Tenor D, Berenguer J, García-Broncano P, Jiménez-Sousa MA, Fernández-Rodríguez A, Diez C, García-Álvarez M, Carrero A, Catalán P, Aldámiz-Echevarria T, Resino S.

Eur J Clin Invest. 2014 May;44(5):453-62. doi: 10.1111/eci.12250. Epub 2014 Mar 7.

PMID:
24528335
20.

SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients.

Pineda-Tenor D, Micheloud D, Berenguer J, Jiménez-Sousa MA, Fernández-Rodríguez A, García-Broncano P, Guzmán-Fulgencio M, Diez C, Bellón JM, Carrero A, Aldámiz-Echevarria T, García-Álvarez M, Resino S.

AIDS. 2014 Jun 1;28(9):1325-32. doi: 10.1097/QAD.0000000000000215.

PMID:
24499956
21.

Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers.

Fernández-Rodríguez A, Berenguer J, Jiménez-Sousa MA, Guzmán-Fulgencio M, Micheloud D, Miralles P, López JC, Bellón JM, Aldamiz-Echevarria T, García-Broncano P, Carrero A, Alvarez E, Resino S.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):434-42. doi: 10.1097/QAI.0b013e3182a06eb6.

PMID:
23797694

Supplemental Content

Loading ...
Support Center